Skip to Content

Home

register now

Fifteenth Annual Innovative Molecular Analysis Technologies (IMAT)
Principal Investigators (PI) Meeting
November 12-13, 2014 – Bethesda, MD

We are pleased to announce the National Cancer Institute's (NCI) Fifteenth Annual Innovative Molecular Analysis Technologies (IMAT) Principle Investigators’ (PI) Meeting is to be held on November 12-13, 2014 at the Porter Neuroscience Conference Center (Building 35A, lower level) on the NIH Campus in Bethesda, MD. This annual meeting is organized to address two important aims of the IMAT program: (1) to provide NCI program staff a chance to interact directly with PIs and receive an update on progress to date of supported research and (2) to provide an opportunity for interactions and exchange of ideas among meeting participants. This latter aim is a critical opportunity for sparking potentially transformative project collaborations, receiving critical feedback and guidance from the community, as well as for fostering dissemination of the exciting technologies emerging from IMAT-supported researchers.

As there are more exciting active research projects in the IMAT portfolio than we could possibly allow sufficient speaking time for, we are continuing the short "Poster Highlights" presentations as we have done in previous years, in which a number of investigators will give short overview talks on their research, noting that more detailed information may be gleaned from their posters. We will also continue to keep the meeting open to all interested local area researchers, clinicians and students.

The National Cancer Institute (NCI) has made a strong commitment to supporting the development and application of novel and potentially paradigm-shifting technologies in the Nation's continuing battle against cancer. Since 1998, the Innovative Molecular Analysis Technologies (IMAT, http://innovation.cancer.gov) program has been a key component of this effort, supporting innovative and emerging technologies of interest for cancer research and clinical care. On behalf of the NCI program staff and everyone involved in the planning for this meeting, I thank you for your participation, your interest, and the important work you all do to assist in our collective mission against cancer. I look forward to an exciting and productive meeting.

Kind Regards,
Tony Dickherber, Ph.D.
IMAT Program Director
Innovative Molecular Analysis Technologies Program
Center for Strategic Scientific Initiative